Published in J Clin Endocrinol Metab on October 01, 1980
Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid (2008) 1.18
Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Oncol (2008) 1.06
Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. J Clin Invest (1998) 0.99
Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer. Oncotarget (2016) 0.77
Thyrotrophin receptors, tumour radioiodine concentration and thyroglobulin secretion in differentiated thyroid cancers. Br J Cancer (1985) 0.75
Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res (1971) 13.16
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol (1989) 5.44
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem (1995) 4.53
Low-dose risk assessment. Radiat Res (2007) 2.88
Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab (1986) 2.70
Repair of potentially lethal radiation damage in vitro and in vivo. Radiology (1973) 2.43
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
The link between local recurrence and distant metastases in human breast cancer. Int J Radiat Oncol Biol Phys (1999) 2.10
Cell proliferation kinetics in five human solid tumors. Cancer (1968) 1.92
Relation between the pathological nature and the growth rate of human tumors. Eur J Cancer (1971) 1.92
Specific pattern of RAS oncogene mutations in follicular thyroid tumors. J Clin Endocrinol Metab (2003) 1.91
Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett (1985) 1.91
Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys (1991) 1.77
Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer (1984) 1.71
The relationship between growth rate, labelling index and histological type of human solid tumours. Eur J Cancer (1973) 1.68
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer (1985) 1.66
[Growth rate and natural history of breast cancer]. Bull Cancer (1976) 1.61
Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes? Cancer (1990) 1.55
Cannabinoid-receptor expression in human leukocytes. Eur J Biochem (1993) 1.53
The long-term prognostic significance of the thymidine labelling index in breast cancer. Int J Cancer (1984) 1.51
Subcellular localization of peripheral benzodiazepine receptors on human leukocytes. Lab Invest (1994) 1.50
L.H. Gray Medal lecture: cell kinetics and radiation oncology. Int J Radiat Oncol Biol Phys (1982) 1.46
Presence of mutations in all three ras genes in human thyroid tumors. Oncogene (1990) 1.42
Interleukin 13 is a B cell stimulating factor. J Exp Med (1994) 1.41
Kinetics of cell proliferation of an experimental tumor. Cancer Res (1967) 1.38
Kinetic parameters and the course of the disease in breast cancer. Cancer (1981) 1.30
Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies. J Immunol Methods (1985) 1.30
External radiotherapy in thyroid cancers. Cancer (1985) 1.28
Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J (Clin Res Ed) (1982) 1.25
Relationship between immunological structure and biochemical properties of human thyroid peroxidase. Endocrinology (1989) 1.23
Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem (2000) 1.22
Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer (2000) 1.15
Specificity of monoclonal antibodies against human thyroglobulin; comparison with autoimmune antibodies. EMBO J (1983) 1.15
Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system. J Pharmacol Exp Ther (1998) 1.14
Purification and characterization of the human SR 31747A-binding protein. A nuclear membrane protein related to yeast sterol isomerase. J Biol Chem (1997) 1.13
Detection of activated ras oncogenes in human thyroid carcinomas. Oncogene (1988) 1.12
Acupuncture in gastroscopy. Lancet (1978) 1.11
The causes of cancer in France. Ann Oncol (2008) 1.11
Non-Hodgkin's malignant lymphomata of upper digestive and respiratory tract: natural history and results of radiotherapy. Br J Cancer Suppl (1975) 1.11
Theory and practice for the implementation of 'in-house', continuous improvement participatory ergonomic programs. Appl Ergon (1998) 1.10
Increased high-molecular-weight thyrotropin with impaired biologic activity in a euthyroid man. N Engl J Med (1981) 1.10
Mycophenolate mofetil-induced villous atrophy. Transplantation (1998) 1.09
Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. Mol Pharmacol (1999) 1.09
Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol (2001) 1.08
Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about? Ann Oncol (2003) 1.08
Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells. Br J Cancer (2001) 1.07
Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sci (1993) 1.06
Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab (1987) 1.05
A simulation model of the natural history of human breast cancer. Br J Cancer (1985) 1.02
[Data on the rate of growth of human tumors]. Bull Cancer (1971) 1.00
Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. J Clin Endocrinol Metab (1994) 0.99
Colocalization of sterol isomerase and sigma(1) receptor at endoplasmic reticulum and nuclear envelope level. Eur J Biochem (1999) 0.99
A technique for determining the proportion of the clonogenic cells in S phase in ENT6 cell cultures and tumors. Cell Tissue Kinet (1976) 0.99
Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. FASEB J (2008) 0.98
[Epithelioma of the thyroid secreting thyrocalcitonin]. C R Acad Sci Hebd Seances Acad Sci D (1968) 0.98
Pericarditis and myocardial infarctions after Hodgkin's disease therapy. Int J Radiat Oncol Biol Phys (1991) 0.98
The kinetics of tumour cell proliferation and radiotherapy. Br J Radiol (1971) 0.98
Congenital hypothyroidism associated with thyrotropin unresponsiveness and thyroid cell membrane alterations. J Clin Endocrinol Metab (1980) 0.98
Polyphenols and cancer cell growth. Rev Physiol Biochem Pharmacol (2007) 0.98
Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice. Am J Gastroenterol (2001) 0.98
Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation. Ann N Y Acad Sci (1991) 0.97
Prognostic factors in 454 cases of Hodgkin's disease. Cancer Res (1971) 0.96
Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol (1988) 0.96
Long-term results of the E.O.R.T.C. randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin's disease. Eur J Cancer (1979) 0.95
Acute pancreatitis following gastrointestinal endoscopy without ampullary cannulation. Endoscopy (1982) 0.95
Determination at the molecular level of a B-cell epitope on thyroid peroxidase likely to be associated with autoimmune thyroid disease. J Clin Endocrinol Metab (1991) 0.95
Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites. J Neurochem (1985) 0.95
Experiences of technology integration in home care nursing. AMIA Annu Symp Proc (2008) 0.94
The influence of cell proliferation in tumours and normal tissues during fractionated radiotherapy. Eur J Cancer (1971) 0.93
Effects of therapy with T101 ricin A-chain immunotoxin in two leukemia patients. Blood (1986) 0.93
A study of hematological complications occurring in patients with polycythemia vera treated with 32-P (based on a series of 296 patients). Blood (1968) 0.93
Various expressions of a unique anti-human thyroglobulin antibody repertoire in normal state and autoimmune disease. Eur J Immunol (1985) 0.92
Human thyroglobulin reference material (CRM 457). 2nd Part: Physicochemical characterization and certification. Ann Biol Clin (Paris) (1996) 0.92
Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth. Cancer Res (1995) 0.92
Immunopharmacological profile of SR 31747: in vitro and in vivo studies on humoral and cellular responses. J Neuroimmunol (1994) 0.91
Expression of tpo mRNA in thyroid tumors: quantitative PCR analysis and correlation with alterations of ret, Braf , ras and pax8 genes. Endocr Relat Cancer (2006) 0.91
The EORTC treatment of early stages of Hodgkin's disease: the role of radiotherapy. Int J Radiat Oncol Biol Phys (1984) 0.91
Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relationship to serum thyrotropin levels. J Clin Endocrinol Metab (1980) 0.90
Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies. J Clin Endocrinol Metab (1996) 0.90
Medullary thyroid carcinoma: prognostic factors and treatment. Int J Radiat Oncol Biol Phys (1983) 0.90
Generation cycle of mouse bone marrow. Nature (1967) 0.90
Prolactin secreting tumors. Endocrine status before and after surgery in 33 women. J Clin Endocrinol Metab (1978) 0.90
Prognostic significance of the number of involved areas in the early stages of Hodgkin's disease. Cancer (1984) 0.90
Comparison of serum thyroid microsomal and thyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab (1987) 0.90
Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab (1993) 0.90
Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med (1988) 0.90
Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line. Eur J Pharmacol (1996) 0.90
[Growth of the cells of an experimental irradiated fibrosarcoma in the C3H mouse]. C R Acad Sci Hebd Seances Acad Sci D (1966) 0.89
Risk of cancer from diagnostic X-rays. Lancet (2004) 0.89
The interaction of radioiodinated thyrotropin with human plasma membranes from normal and diseased thyroid glands. Relation of thyrotropin binding to adenylate cyclase activity. Ann Endocrinol (Paris) (1979) 0.89
The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol (1996) 0.89
Immunoglobulin G kappa antithyroid peroxidase antibodies in Hashimoto's thyroiditis: epitope-mapping analysis. J Clin Endocrinol Metab (1997) 0.89
Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Eur J Pharmacol (1997) 0.89
ret/PTC1 and ret/PTC3 in thyroid tumors from Chernobyl liquidators: comparison with sporadic tumors from Ukrainian and French patients. Endocr Relat Cancer (2005) 0.89
Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor. J Biol Chem (1999) 0.89
Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma. Mol Pharmacol (1984) 0.89
Immunohistochemical study of thyroid peroxidase in normal, hyperplastic, and neoplastic human thyroid tissues. Cancer (1991) 0.89
External radiotherapy and radionuclide in the treatment of thyroid cancer. World J Surg (1981) 0.88
Hydrogen peroxide-induced production of a 40 kDa immunoreactive thyroglobulin fragment in human thyroid cells: the onset of thyroid autoimmunity? Biochem J (2001) 0.88
The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases. Br J Cancer (1989) 0.88